Eagle Pharmaceuticals to Present at the Barclays Global Healthcare Conference

Rhea-AI Summary

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) announced that CEO Scott Tarriff and CFO Brian Cahill will participate in a fireside chat at the Barclays Global Healthcare Conference on March 15, 2023, at 2:35 PM ET. This event will take place in Miami, FL, and will be available via webcast. Eagle Pharmaceuticals is committed to innovation in medicines that enhance patients' lives, with a diverse product portfolio and a strong pipeline targeting critical areas in oncology and metabolic care.

News Market Reaction – EGRX

-1.65%

-1.65% Session move

In the trading session that priced this news, EGRX declined 1.65%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WOODCLIFF LAKE, N.J., March 09, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will participate in a fireside chat at the Barclays Global Healthcare Conference, in Miami, FL, as follows:

Date:	Wednesday, March 15, 2023
Time:	2:35pm ET
Webcast:	Click Here

To schedule a 1x1 meeting, please contact your Barclays representative.

About Eagle Pharmaceuticals, Inc.
Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include vasopressin, PEMFEXY®, RYANODEX®, BENDEKA®, BELRAPZO®, TREAKISYM® (Japan), and BYFAVO® and BARHEMSYS® through its wholly owned subsidiary Acacia Pharma Inc. Eagle’s oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.

Investor Relations for Eagle Pharmaceuticals, Inc.:
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

FAQ

When will Eagle Pharmaceuticals participate in the Barclays Global Healthcare Conference?

Eagle Pharmaceuticals will participate in the Barclays Global Healthcare Conference on March 15, 2023.

What time is Eagle Pharmaceuticals' fireside chat at the conference?

The fireside chat will begin at 2:35 PM ET.

Where is the Barclays Global Healthcare Conference being held?

The conference is held in Miami, FL.

How can I access the webcast of Eagle Pharmaceuticals' fireside chat?

You can access the webcast by clicking here.

Who will represent Eagle Pharmaceuticals at the Barclays conference?

Scott Tarriff, CEO, and Brian Cahill, CFO, will represent Eagle Pharmaceuticals.